Evidence map›Paper›PMID 42011338›Full record

ArticleAdvances in radiation oncology2026

Global Assessment of Megavoltage External Beam Radiation Therapy Facilities: Current Status and Projections for 2030-2050.

Fatemeh Sadat Tabatabaei, Amirali Azimi, Romina Abyaneh, Felipe Couñago, Filippo Alongi, Nina N Sanford, Reza Ghalehtaki

Abstract read
In one paragraph

Article in Advances in radiation oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Fatemeh Sadat TabatabaeiCenter for Immunology and Inflammatory Diseases, Division of Rheumatology, Allergy and Immunology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.
Amirali AzimiRadiation Oncology Research Center, Cancer Research Institute, Tehran University of Medical Sciences, Tehran, Iran.
Romina AbyanehRadiation Oncology Research Center, Cancer Research Institute, Tehran University of Medical Sciences, Tehran, Iran.
Felipe CouñagoDepartment of Radiation Oncology, Hospital Universitario San Francisco de Asís, GenesisCare, Madrid, Spain.
Filippo AlongiAdvanced Radiation Oncology Department, IRCCS Ospedale Sacro Cuore Don Calabria, Negrar, Italy.
Nina N SanfordDepartment of Radiation Oncology, University of Texas Southwestern Medical Center, Dallas, Texas.
Reza GhalehtakiRadiation Oncology Research Center, Cancer Research Institute, Tehran University of Medical Sciences, Tehran, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: This study evaluates the worldwide distribution of radiation therapy (RT) facilities, focusing on current accessibility and projected needs at multiple future time points (2025, 2030, 2035, 2040, 2045, and 2050). Methods and Materials: Data were obtained from the World Bank, GLOBOCAN, and the International Atomic Energy Agency Directory of Radiotherapy Centres. A comprehensive projection model was developed that incorporates: (1) sensitivity analysis of machine throughput (patients per machine per year), (2) reirradiation rates stratified by country income level, (3) both country-specific and cancer-specific RT utilization rates, and (4) adjustments for the contribution of brachytherapy facilities. Results: Globally, there were 18.7 million new patients with cancer in 2022, of whom an estimated 11.2 million required RT. Of 215 countries and territories listed by the World Bank, 35 reported no data or zero RT facilities in Directory of Radiotherapy Centre, corresponding to a need for 362 MV RT machines by 2045. For the 146 countries with available data, 16,941 MV RT machines were reported, yielding a global patient coverage of 68% and a deficit of 7944 machines in 2022. Only 5.8% of the operating equipment is younger than 5 years. Projections indicate that by 2045, 16.7 million patients will require RT, necessitating 20,255 MV additional therapy units. Conclusions: This study underscores the persistent challenges in achieving equitable RT accessibility globally. The identified gaps extend beyond economic classifications, emphasizing the necessity for targeted interventions and strategic resource allocation to address the growing demand for RT and ensure comprehensive cancer care worldwide.

Identifiers

PMID42011338
PMCPMC13092090

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.